Wells Fargo’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Wells Fargo's NVS Position: Q1 2026 in Review
Wells Fargo increased its Novartis (NVS) stake by 2.9% in Q1 2026, buying an estimated $8.22M and bringing the position to 1,895,677 shares worth $290M. The position accounts for 0.05% of the portfolio, ranked #287.
Wells Fargo first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $760M in Q2 2015. 1,591 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Wells Fargo held 1,895,677 shares of Novartis worth $290M as of Q1 2026.
- Wells Fargo bought 53,634 Novartis shares in Q1 2026, an estimated $8.22M.
- Novartis made up 0.05% of Wells Fargo's portfolio in Q1 2026, its #287 holding.
- Wells Fargo first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
- Wells Fargo's Novartis position peaked at $760M in Q2 2015.
- 1,591 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.